The discovery of B-cell lymphoma 2 (BCL2) family proteins further emphasized the importance of mitochondria in controlling apoptosis, linking these organelles to cancer cell survival and therapy resistance.20 In the 1990s, ROS emerged as key mediators of cancer mitochondrial signaling. This evidence concerns the gene BCL2 and cancer.